These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28940371

  • 1. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M, Meurer SK, Kloten V, Weiskirchen R, Denecke B, Antonopoulos W, Deckert M, Knüchel R, Dahl E.
    Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
    [Abstract] [Full Text] [Related]

  • 2. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
    Rose M, Kloten V, Noetzel E, Gola L, Ehling J, Heide T, Meurer SK, Gaiko-Shcherbak A, Sechi AS, Huth S, Weiskirchen R, Klaas O, Antonopoulos W, Lin Q, Wagner W, Veeck J, Gremse F, Steitz J, Knüchel R, Dahl E.
    Mol Cancer; 2017 Feb 23; 16(1):44. PubMed ID: 28231808
    [Abstract] [Full Text] [Related]

  • 3. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
    Veeck J, Breuer E, Rose M, Chorovicer M, Naami A, Bektas N, Alkaya S, von Serényi S, Horn F, Hartmann A, Knüchel R, Dahl E.
    Pathologe; 2008 Nov 23; 29 Suppl 2():338-46. PubMed ID: 18810445
    [Abstract] [Full Text] [Related]

  • 4. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.
    Oncogene; 2008 Jan 31; 27(6):865-76. PubMed ID: 17653090
    [Abstract] [Full Text] [Related]

  • 5. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.
    Henry LA, Johnson DA, Sarrió D, Lee S, Quinlan PR, Crook T, Thompson AM, Reis-Filho JS, Isacke CM.
    Oncogene; 2011 Mar 03; 30(9):1046-58. PubMed ID: 21042283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
    Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.
    Carcinogenesis; 2014 Mar 03; 35(3):727-36. PubMed ID: 24265292
    [Abstract] [Full Text] [Related]

  • 8. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
    Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL, Tsao SW, Srivastava G, Lung ML.
    Int J Cancer; 2008 Dec 15; 123(12):2816-23. PubMed ID: 18798555
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype.
    Kloten V, Rose M, Kaspar S, von Stillfried S, Knüchel R, Dahl E.
    Epigenetics; 2014 Sep 15; 9(9):1290-301. PubMed ID: 25093535
    [Abstract] [Full Text] [Related]

  • 10. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM, Kloten V, Schlensog M, Heide T, Braunschweig T, Veeck J, Petersen I, Knüchel R, Dahl E.
    Epigenetics; 2015 Sep 15; 10(10):903-12. PubMed ID: 26252352
    [Abstract] [Full Text] [Related]

  • 11. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
    Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR.
    Clin Exp Metastasis; 2017 Apr 15; 34(3-4):229-239. PubMed ID: 28289921
    [Abstract] [Full Text] [Related]

  • 12. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF, Wu MY, Lin YC, Kannagi R, Yang RB.
    Breast Cancer Res; 2017 Oct 05; 19(1):111. PubMed ID: 28982386
    [Abstract] [Full Text] [Related]

  • 13. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
    Kokaji E, Shimomura A, Minamisaka T, Nakajima T, Miwa S, Hatta H, Nishida T, Kiya C, Imura J.
    Int J Oncol; 2018 Mar 05; 52(3):892-900. PubMed ID: 29393426
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migration.
    Kosinski J, Sechi A, Hain J, Villwock S, Ha SA, Hauschulz M, Rose M, Steib F, Ortiz-Brüchle N, Heij L, Maas SL, van der Vorst EPC, Knoesel T, Altendorf-Hofmann A, Simon R, Sauter G, Bednarsch J, Jonigk D, Dahl E.
    Mol Oncol; 2024 Jun 05; 18(6):1486-1509. PubMed ID: 38375974
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
    Kloten V, Becker B, Winner K, Schrauder MG, Fasching PA, Anzeneder T, Veeck J, Hartmann A, Knüchel R, Dahl E.
    Breast Cancer Res; 2013 Jan 15; 15(1):R4. PubMed ID: 23320751
    [Abstract] [Full Text] [Related]

  • 17. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ.
    Cancer Res; 2007 Dec 15; 67(24):11517-27. PubMed ID: 18089780
    [Abstract] [Full Text] [Related]

  • 18. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M, Schoonderwoerd MJA, Helderman RFCP, Harryvan TJ, Groenewoud A, van Pelt GW, Bor R, Hemmer DM, Versteeg HH, Snaar-Jagalska BE, Theuer CP, Hardwick JCH, Sier CFM, Ten Dijke P, Hawinkels LJAC.
    Clin Cancer Res; 2018 Dec 15; 24(24):6331-6344. PubMed ID: 29945992
    [Abstract] [Full Text] [Related]

  • 19. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 20. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M, Schubert C, Dierichs L, Gaisa NT, Heer M, Heidenreich A, Knüchel R, Dahl E.
    Epigenetics; 2014 Dec 01; 9(12):1626-40. PubMed ID: 25625847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.